EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting the JAK/STAT signalling axis in cancer: chemopreventive potential of natural compounds with emerging focus on retinoids

Ayesha Jabeen, Tabish Javeed, Nusrat Jan, Shazia Sofi, Gowhar Masoodi, Showkat Ahmad Ahanger, Manzoor Ahmad Mir

Clinical and Translational Oncology · 21.08.2026

DOI: 10.1007/s12094-026-04540-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, online erschienen am 21.08.2026. Verfasst von Ayesha Jabeen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology Laboratory, Department of Bioresources, School of Biological Sciences, University of Kashmir, Srinagar, 190006, India. Die Arbeit nennt 156 Literaturangaben. Gefördert von: ANRF-SERB-DST Government of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aberrant activation of the Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway, particularly STAT3, contributes to tumour progression, metastasis, immune evasion, and therapeutic resistance, making it an attractive target for cancer prevention and therapy. Numerous natural compounds have been reported to modulate this pathway in preclinical studies; however, their clinical translation remains constrained by limited mechanistic validation and poor pharmacokinetic properties. Retinoids, well established as regulators of cellular differentiation and proliferation, have recently emerged as potential modulators of JAK/STAT signalling, although the molecular basis of this interaction remains poorly understood. This review critically evaluates current evidence linking natural compounds with JAK/STAT inhibition, with particular emphasis on the emerging retinoidJAK/STAT interface. By distinguishing established findings from hypothesis-generating observations, identifying key mechanistic gaps, and outlining future experimental priorities, this review provides a framework for evaluating the therapeutic potential of retinoid-mediated JAK/STAT modulation in cancer.

Schlagwörter

Stichwörter der Autor:innen

CancerCancer chemopreventionJAK/STAT signalling pathwayNatural compoundsRetinoidsSTAT3Signal transductionTargeted therapy

Autor:innen und Institutionen

  • Cancer Biology Laboratory, Department of Bioresources, School of Biological Sciences, University of Kashmir, Srinagar, 190006, India.
  • Cancer Biology Laboratory, Department of Bioresources, School of Biological Sciences, University of Kashmir, Srinagar, 190006, India. drmanzoor@kashmiruniversity.ac.in.

Förderung

  • ANRF-SERB-DST Government of India

Zitieren

APA

Jabeen, A., Javeed, T., Jan, N., Sofi, S., Masoodi, G., Ahmad Ahanger, S., & Mir, M. A. (2026). Targeting the JAK/STAT signalling axis in cancer: chemopreventive potential of natural compounds with emerging focus on retinoids. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04540-0

Vancouver

Jabeen A, Javeed T, Jan N, Sofi S, Masoodi G, Ahmad Ahanger S, et al. Targeting the JAK/STAT signalling axis in cancer: chemopreventive potential of natural compounds with emerging focus on retinoids. Clinical and Translational Oncology. 2026. doi:10.1007/s12094-026-04540-0

BibTeX
@article{Jabeen2026,
  author = {Jabeen, Ayesha and Javeed, Tabish and Jan, Nusrat and Sofi, Shazia and Masoodi, Gowhar and Ahmad Ahanger, Showkat and Mir, Manzoor Ahmad},
  title = {Targeting the JAK/STAT signalling axis in cancer: chemopreventive potential of natural compounds with emerging focus on retinoids},
  journal = {Clinical and Translational Oncology},
  year = {2026},
  doi = {10.1007/s12094-026-04540-0}
}
Kostenlos starten →